Journal of Bioanalysis & Biomedicine

8^th Asian Biologics and Biosimilars Congress

August 10-12, 2017 Beijing, China

Posters & Accepted Abstracts

• Theodor Bilharz Research Institute therapeutic products and health tools

  Ismail Mohamed Rafeky Hussein Saad

  PDF HTML

• Some considerations about biosimilar safety

  Samer M Al-Hulu

  PDF HTML

• Biosimilars: Marketing, development, regulations and molecules approved in Australia, Brazil, Malaysia, Japan, Singapore and South Korea

  Tomas Gabriel BAS

  PDF HTML

• Medicines distributions and financing alternatives

  Abdeen M Omer

  PDF HTML

• Global status of biosimilars and prospects in Asia

  Md Abu Zafor Sadek

  PDF HTML

• Bioassay-directed isolation of hypotensive alkaloids from Holarrhena pubescens

  K Aftab, S B Usmani, S Begum and B S Siddiqui

  PDF HTML

• Evaluation of the cytotoxicity of an Oscillatoria sp. extract on breast cancer cell line (MCF-7) and assessment of NoxA gene expression

  Ali Salehzadeh and Akram Sadat Naeemi

  PDF HTML

• The study of antimicrobial and anti-Alzheimers effects of turmeric extract based on amyloid nano-biofibrils formation inhibition method

  Amir Arasteh and Zahra Sayyadi Ghasabeh

  PDF HTML

• Heterogeneity of monoclonal antibody and challenges in developing biosimilar of it

  Sunit Maity

  PDF HTML

• Biosimilar globalization, a silver lining in untested waters! Biosimilars in China: Balance of risks and opportunities

  Candida Fratazzi

  PDF HTML

• Update on biosimilars litigation in the United States

  George C Yu

  PDF HTML

• Current status in the development of biosimilar market in LATAM region: An update on market barriers, opportunities and regulatory requirements

  Edgar Mauricio Rubio

  PDF HTML

• Significance of stability and temperature excursion studies for biologistics

  Rajiv Dua

  PDF HTML